APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Bacille Calmette-Guerin Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bacille Calmette-Guerin Vaccine Industry Growth and Trends Forecast to 2032

Report ID 173968940128 December 2025109 pages

Choose your research edition.

Industry ResearchBacille Calmette-Guerin Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Bacille Calmette-Guerin Vaccine Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Bacille Calmette-Guerin Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bacille Calmette-Guerin Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Bacille Calmette-Guerin Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Bacille Calmette-Guerin Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bacille Calmette-Guerin Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bacille Calmette-Guerin Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bacille Calmette-Guerin Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bacille Calmette-Guerin Vaccine include China National Biotec, Merck, Taj Pharmaceuticals, Serum Institute of India, Queen Saovabha Mem. Inst, Microgen, Japan BCG Lab, IVAC – Institute of Vaccines and Medical Biologicals and GreenSignal Bio Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bacille Calmette-Guerin Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bacille Calmette-Guerin Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bacille Calmette-Guerin Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bacille Calmette-Guerin Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bacille Calmette-Guerin Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bacille Calmette-Guerin Vaccine Market by Company

China National Biotec

Merck

Taj Pharmaceuticals

Serum Institute of India

Queen Saovabha Mem. Inst

Microgen

Japan BCG Lab

IVAC – Institute of Vaccines and Medical Biologicals

GreenSignal Bio Pharma

Biomed Lublin

BioFarma

Ataulpho de Paiva

AJ Vaccines

Bacille Calmette-Guerin Vaccine Segment by Type

Immune Vaccine

Therapy Vaccine

Bacille Calmette-Guerin Vaccine Segment by Application

Self-Procurement

UNICEF

Other

Bacille Calmette-Guerin Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bacille Calmette-Guerin Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bacille Calmette-Guerin Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bacille Calmette-Guerin Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bacille Calmette-Guerin Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bacille Calmette-Guerin Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Immune Vaccine Table 2. Major Company of Therapy Vaccine Table 3. Global Bacille Calmette-Guerin Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Bacille Calmette-Guerin Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Bacille Calmette-Guerin Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Bacille Calmette-Guerin Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Bacille Calmette-Guerin Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Bacille Calmette-Guerin Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Bacille Calmette-Guerin Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Bacille Calmette-Guerin Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Bacille Calmette-Guerin Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Bacille Calmette-Guerin Vaccine Industry Trends Table 25. Bacille Calmette-Guerin Vaccine Industry Drivers Table 26. Bacille Calmette-Guerin Vaccine Industry Opportunities and Challenges Table 27. Bacille Calmette-Guerin Vaccine Industry Restraints Table 28. Global Bacille Calmette-Guerin Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Bacille Calmette-Guerin Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Bacille Calmette-Guerin Vaccine Sales Share by Company (2021-2026) Table 32. Global Bacille Calmette-Guerin Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Bacille Calmette-Guerin Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Bacille Calmette-Guerin Vaccine Major Company Production Sites and Headquarters Table 35. Global Bacille Calmette-Guerin Vaccine Company, Product Type & Application Table 36. Global Bacille Calmette-Guerin Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Bacille Calmette-Guerin Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Bacille Calmette-Guerin Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Bacille Calmette-Guerin Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Bacille Calmette-Guerin Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Bacille Calmette-Guerin Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Bacille Calmette-Guerin Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Bacille Calmette-Guerin Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Bacille Calmette-Guerin Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Bacille Calmette-Guerin Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Bacille Calmette-Guerin Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Bacille Calmette-Guerin Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Bacille Calmette-Guerin Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Bacille Calmette-Guerin Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Bacille Calmette-Guerin Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Bacille Calmette-Guerin Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Bacille Calmette-Guerin Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Bacille Calmette-Guerin Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Bacille Calmette-Guerin Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Bacille Calmette-Guerin Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Bacille Calmette-Guerin Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Bacille Calmette-Guerin Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. China National Biotec Company Information Table 72. China National Biotec Business Overview Table 73. China National Biotec Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. China National Biotec Bacille Calmette-Guerin Vaccine Product Portfolio Table 75. China National Biotec Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Merck Bacille Calmette-Guerin Vaccine Product Portfolio Table 80. Merck Recent Development Table 81. Taj Pharmaceuticals Company Information Table 82. Taj Pharmaceuticals Business Overview Table 83. Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Product Portfolio Table 85. Taj Pharmaceuticals Recent Development Table 86. Serum Institute of India Company Information Table 87. Serum Institute of India Business Overview Table 88. Serum Institute of India Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Serum Institute of India Bacille Calmette-Guerin Vaccine Product Portfolio Table 90. Serum Institute of India Recent Development Table 91. Queen Saovabha Mem. Inst Company Information Table 92. Queen Saovabha Mem. Inst Business Overview Table 93. Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Product Portfolio Table 95. Queen Saovabha Mem. Inst Recent Development Table 96. Microgen Company Information Table 97. Microgen Business Overview Table 98. Microgen Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Microgen Bacille Calmette-Guerin Vaccine Product Portfolio Table 100. Microgen Recent Development Table 101. Japan BCG Lab Company Information Table 102. Japan BCG Lab Business Overview Table 103. Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Japan BCG Lab Bacille Calmette-Guerin Vaccine Product Portfolio Table 105. Japan BCG Lab Recent Development Table 106. IVAC – Institute of Vaccines and Medical Biologicals Company Information Table 107. IVAC – Institute of Vaccines and Medical Biologicals Business Overview Table 108. IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Product Portfolio Table 110. IVAC – Institute of Vaccines and Medical Biologicals Recent Development Table 111. GreenSignal Bio Pharma Company Information Table 112. GreenSignal Bio Pharma Business Overview Table 113. GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Product Portfolio Table 115. GreenSignal Bio Pharma Recent Development Table 116. Biomed Lublin Company Information Table 117. Biomed Lublin Business Overview Table 118. Biomed Lublin Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Biomed Lublin Bacille Calmette-Guerin Vaccine Product Portfolio Table 120. Biomed Lublin Recent Development Table 121. BioFarma Company Information Table 122. BioFarma Business Overview Table 123. BioFarma Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. BioFarma Bacille Calmette-Guerin Vaccine Product Portfolio Table 125. BioFarma Recent Development Table 126. Ataulpho de Paiva Company Information Table 127. Ataulpho de Paiva Business Overview Table 128. Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Product Portfolio Table 130. Ataulpho de Paiva Recent Development Table 131. AJ Vaccines Company Information Table 132. AJ Vaccines Business Overview Table 133. AJ Vaccines Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. AJ Vaccines Bacille Calmette-Guerin Vaccine Product Portfolio Table 135. AJ Vaccines Recent Development Table 136. North America Bacille Calmette-Guerin Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. North America Bacille Calmette-Guerin Vaccine Sales by Country (2021-2026) & (K Units) Table 138. North America Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2021-2026) Table 139. North America Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 140. North America Bacille Calmette-Guerin Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. North America Bacille Calmette-Guerin Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Bacille Calmette-Guerin Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Bacille Calmette-Guerin Vaccine Market Share by Country (2021-2026) Table 144. North America Bacille Calmette-Guerin Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Bacille Calmette-Guerin Vaccine Market Share Forecast by Country (2027-2032) Table 146. Europe Bacille Calmette-Guerin Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Europe Bacille Calmette-Guerin Vaccine Sales by Country (2021-2026) & (K Units) Table 148. Europe Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2021-2026) Table 149. Europe Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 150. Europe Bacille Calmette-Guerin Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Bacille Calmette-Guerin Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Bacille Calmette-Guerin Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Bacille Calmette-Guerin Vaccine Market Share by Country (2021-2026) Table 154. Europe Bacille Calmette-Guerin Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Bacille Calmette-Guerin Vaccine Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Bacille Calmette-Guerin Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Bacille Calmette-Guerin Vaccine Sales by Country (2021-2026) & (K Units) Table 158. Asia-Pacific Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 160. Asia-Pacific Bacille Calmette-Guerin Vaccine Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Bacille Calmette-Guerin Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Bacille Calmette-Guerin Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Bacille Calmette-Guerin Vaccine Market Share by Country (2021-2026) Table 164. Asia-Pacific Bacille Calmette-Guerin Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Bacille Calmette-Guerin Vaccine Market Share Forecast by Country (2027-2032) Table 166. Latin America Bacille Calmette-Guerin Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Latin America Bacille Calmette-Guerin Vaccine Sales by Country (2021-2026) & (K Units) Table 168. Latin America Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2021-2026) Table 169. Latin America Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 170. Latin America Bacille Calmette-Guerin Vaccine Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Bacille Calmette-Guerin Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Bacille Calmette-Guerin Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Bacille Calmette-Guerin Vaccine Market Share by Country (2021-2026) Table 174. Latin America Bacille Calmette-Guerin Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Bacille Calmette-Guerin Vaccine Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Bacille Calmette-Guerin Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales by Country (2021-2026) & (K Units) Table 178. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 180. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Bacille Calmette-Guerin Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Bacille Calmette-Guerin Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Bacille Calmette-Guerin Vaccine Market Share by Country (2021-2026) Table 184. Middle East and Africa Bacille Calmette-Guerin Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Bacille Calmette-Guerin Vaccine Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Bacille Calmette-Guerin Vaccine Distributors List Table 189. Bacille Calmette-Guerin Vaccine Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Bacille Calmette-Guerin Vaccine Image Figure 2. Global Bacille Calmette-Guerin Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bacille Calmette-Guerin Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Bacille Calmette-Guerin Vaccine Sales (2021-2032) & (K Units) Figure 5. Immune Vaccine Image Figure 6. Global Immune Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Therapy Vaccine Image Figure 8. Global Therapy Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Bacille Calmette-Guerin Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Bacille Calmette-Guerin Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Bacille Calmette-Guerin Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Bacille Calmette-Guerin Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Bacille Calmette-Guerin Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Bacille Calmette-Guerin Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Bacille Calmette-Guerin Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Bacille Calmette-Guerin Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Bacille Calmette-Guerin Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Bacille Calmette-Guerin Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Bacille Calmette-Guerin Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Self-Procurement Image Figure 24. Global Self-Procurement Sales YoY Growth (2021-2032) & (K Units) Figure 25. UNICEF Image Figure 26. Global UNICEF Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Bacille Calmette-Guerin Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Bacille Calmette-Guerin Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Bacille Calmette-Guerin Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Bacille Calmette-Guerin Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Bacille Calmette-Guerin Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Bacille Calmette-Guerin Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Bacille Calmette-Guerin Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Bacille Calmette-Guerin Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Bacille Calmette-Guerin Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Bacille Calmette-Guerin Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Bacille Calmette-Guerin Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Bacille Calmette-Guerin Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Bacille Calmette-Guerin Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Bacille Calmette-Guerin Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Bacille Calmette-Guerin Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Bacille Calmette-Guerin Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Bacille Calmette-Guerin Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Bacille Calmette-Guerin Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Bacille Calmette-Guerin Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Bacille Calmette-Guerin Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Bacille Calmette-Guerin Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Bacille Calmette-Guerin Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Bacille Calmette-Guerin Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Bacille Calmette-Guerin Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Bacille Calmette-Guerin Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Bacille Calmette-Guerin Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Bacille Calmette-Guerin Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Bacille Calmette-Guerin Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Bacille Calmette-Guerin Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Bacille Calmette-Guerin Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Immune Vaccine
  • Therapy Vaccine
Applications
  • Self-Procurement
  • UNICEF
  • Other
Companies covered
  • China National Biotec
  • Merck
  • Taj Pharmaceuticals
  • Serum Institute of India
  • Queen Saovabha Mem. Inst
  • Microgen
  • Japan BCG Lab
  • IVAC – Institute of Vaccines and Medical Biologicals
  • GreenSignal Bio Pharma
  • Biomed Lublin
  • BioFarma
  • Ataulpho de Paiva
  • AJ Vaccines

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bacille Calmette-Guerin Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bacille Calmette-Guerin Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bacille Calmette-Guerin Vaccine Market by Type
  6. 1.3.1 Immune Vaccine
  7. 1.3.2 Therapy Vaccine
  8. 1.4 Global Bacille Calmette-Guerin Vaccine Market Size by Type
  9. 1.4.1 Global Bacille Calmette-Guerin Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Bacille Calmette-Guerin Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Bacille Calmette-Guerin Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Bacille Calmette-Guerin Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Bacille Calmette-Guerin Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Bacille Calmette-Guerin Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Bacille Calmette-Guerin Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Bacille Calmette-Guerin Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bacille Calmette-Guerin Vaccine Industry Trends
  2. 2.2 Bacille Calmette-Guerin Vaccine Industry Drivers
  3. 2.3 Bacille Calmette-Guerin Vaccine Industry Opportunities and Challenges
  4. 2.4 Bacille Calmette-Guerin Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bacille Calmette-Guerin Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Bacille Calmette-Guerin Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Bacille Calmette-Guerin Vaccine Price (2021-2026)
  4. 3.4 Global Bacille Calmette-Guerin Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bacille Calmette-Guerin Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Bacille Calmette-Guerin Vaccine Company, Product Type & Application
  7. 3.7 Global Bacille Calmette-Guerin Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bacille Calmette-Guerin Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bacille Calmette-Guerin Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bacille Calmette-Guerin Vaccine Tier 1, Tier 2, and Tier 3
4 Bacille Calmette-Guerin Vaccine Regional Status and Outlook
  1. 4.1 Global Bacille Calmette-Guerin Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bacille Calmette-Guerin Vaccine Historic Market Size by Region
  3. 4.2.1 Global Bacille Calmette-Guerin Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bacille Calmette-Guerin Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bacille Calmette-Guerin Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bacille Calmette-Guerin Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Bacille Calmette-Guerin Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bacille Calmette-Guerin Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bacille Calmette-Guerin Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bacille Calmette-Guerin Vaccine by Application
  1. 5.1 Bacille Calmette-Guerin Vaccine Market by Application
  2. 5.1.1 Self-Procurement
  3. 5.1.2 UNICEF
  4. 5.1.3 Other
  5. 5.2 Global Bacille Calmette-Guerin Vaccine Market Size by Application
  6. 5.2.1 Global Bacille Calmette-Guerin Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Bacille Calmette-Guerin Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Bacille Calmette-Guerin Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Bacille Calmette-Guerin Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Bacille Calmette-Guerin Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Bacille Calmette-Guerin Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Bacille Calmette-Guerin Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Bacille Calmette-Guerin Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 China National Biotec
  2. 6.1.1 China National Biotec Company Information
  3. 6.1.2 China National Biotec Business Overview
  4. 6.1.3 China National Biotec Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 China National Biotec Bacille Calmette-Guerin Vaccine Product Portfolio
  6. 6.1.5 China National Biotec Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Bacille Calmette-Guerin Vaccine Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Taj Pharmaceuticals
  14. 6.3.1 Taj Pharmaceuticals Company Information
  15. 6.3.2 Taj Pharmaceuticals Business Overview
  16. 6.3.3 Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Product Portfolio
  18. 6.3.5 Taj Pharmaceuticals Recent Developments
  19. 6.4 Serum Institute of India
  20. 6.4.1 Serum Institute of India Company Information
  21. 6.4.2 Serum Institute of India Business Overview
  22. 6.4.3 Serum Institute of India Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Serum Institute of India Bacille Calmette-Guerin Vaccine Product Portfolio
  24. 6.4.5 Serum Institute of India Recent Developments
  25. 6.5 Queen Saovabha Mem. Inst
  26. 6.5.1 Queen Saovabha Mem. Inst Company Information
  27. 6.5.2 Queen Saovabha Mem. Inst Business Overview
  28. 6.5.3 Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Product Portfolio
  30. 6.5.5 Queen Saovabha Mem. Inst Recent Developments
  31. 6.6 Microgen
  32. 6.6.1 Microgen Company Information
  33. 6.6.2 Microgen Business Overview
  34. 6.6.3 Microgen Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Microgen Bacille Calmette-Guerin Vaccine Product Portfolio
  36. 6.6.5 Microgen Recent Developments
  37. 6.7 Japan BCG Lab
  38. 6.7.1 Japan BCG Lab Company Information
  39. 6.7.2 Japan BCG Lab Business Overview
  40. 6.7.3 Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Japan BCG Lab Bacille Calmette-Guerin Vaccine Product Portfolio
  42. 6.7.5 Japan BCG Lab Recent Developments
  43. 6.8 IVAC – Institute of Vaccines and Medical Biologicals
  44. 6.8.1 IVAC – Institute of Vaccines and Medical Biologicals Company Information
  45. 6.8.2 IVAC – Institute of Vaccines and Medical Biologicals Business Overview
  46. 6.8.3 IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Product Portfolio
  48. 6.8.5 IVAC – Institute of Vaccines and Medical Biologicals Recent Developments
  49. 6.9 GreenSignal Bio Pharma
  50. 6.9.1 GreenSignal Bio Pharma Company Information
  51. 6.9.2 GreenSignal Bio Pharma Business Overview
  52. 6.9.3 GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Product Portfolio
  54. 6.9.5 GreenSignal Bio Pharma Recent Developments
  55. 6.10 Biomed Lublin
  56. 6.10.1 Biomed Lublin Company Information
  57. 6.10.2 Biomed Lublin Business Overview
  58. 6.10.3 Biomed Lublin Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Biomed Lublin Bacille Calmette-Guerin Vaccine Product Portfolio
  60. 6.10.5 Biomed Lublin Recent Developments
  61. 6.11 BioFarma
  62. 6.11.1 BioFarma Company Information
  63. 6.11.2 BioFarma Business Overview
  64. 6.11.3 BioFarma Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 BioFarma Bacille Calmette-Guerin Vaccine Product Portfolio
  66. 6.11.5 BioFarma Recent Developments
  67. 6.12 Ataulpho de Paiva
  68. 6.12.1 Ataulpho de Paiva Company Information
  69. 6.12.2 Ataulpho de Paiva Business Overview
  70. 6.12.3 Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Product Portfolio
  72. 6.12.5 Ataulpho de Paiva Recent Developments
  73. 6.13 AJ Vaccines
  74. 6.13.1 AJ Vaccines Company Information
  75. 6.13.2 AJ Vaccines Business Overview
  76. 6.13.3 AJ Vaccines Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 AJ Vaccines Bacille Calmette-Guerin Vaccine Product Portfolio
  78. 6.13.5 AJ Vaccines Recent Developments
7 North America by Country
  1. 7.1 North America Bacille Calmette-Guerin Vaccine Sales by Country
  2. 7.1.1 North America Bacille Calmette-Guerin Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bacille Calmette-Guerin Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bacille Calmette-Guerin Vaccine Market Size by Country
  6. 7.2.1 North America Bacille Calmette-Guerin Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bacille Calmette-Guerin Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Bacille Calmette-Guerin Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bacille Calmette-Guerin Vaccine Sales by Country
  2. 8.1.1 Europe Bacille Calmette-Guerin Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bacille Calmette-Guerin Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bacille Calmette-Guerin Vaccine Market Size by Country
  6. 8.2.1 Europe Bacille Calmette-Guerin Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bacille Calmette-Guerin Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bacille Calmette-Guerin Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bacille Calmette-Guerin Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Bacille Calmette-Guerin Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bacille Calmette-Guerin Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bacille Calmette-Guerin Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Bacille Calmette-Guerin Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bacille Calmette-Guerin Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bacille Calmette-Guerin Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bacille Calmette-Guerin Vaccine Sales by Country
  2. 10.1.1 South America Bacille Calmette-Guerin Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bacille Calmette-Guerin Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bacille Calmette-Guerin Vaccine Market Size by Country
  6. 10.2.1 South America Bacille Calmette-Guerin Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bacille Calmette-Guerin Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Bacille Calmette-Guerin Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bacille Calmette-Guerin Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Bacille Calmette-Guerin Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bacille Calmette-Guerin Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bacille Calmette-Guerin Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Bacille Calmette-Guerin Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bacille Calmette-Guerin Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bacille Calmette-Guerin Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bacille Calmette-Guerin Vaccine Value Chain Analysis
  2. 12.1.1 Bacille Calmette-Guerin Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bacille Calmette-Guerin Vaccine Production Mode & Process
  7. 12.2 Bacille Calmette-Guerin Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bacille Calmette-Guerin Vaccine Distributors
  10. 12.2.3 Bacille Calmette-Guerin Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst